Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
MEI Pharma, Inc. (NASDAQ: MEIP) is a late-stage pharmaceutical company dedicated to developing and commercializing novel, best-in-class therapies for cancer. Their portfolio of drug candidates is focused on epigenetic and other oncology targets. The company aims to address unmet medical needs in cancer treatment by advancing innovative therapies through clinical development, often in combination with other agents to enhance efficacy and patient outcomes.
The headquarters serves as the central hub for MEI Pharma's research and development, clinical operations, corporate strategy, investor relations, and administrative functions.
The facility is situated in a prominent biotech cluster, providing access to a rich ecosystem of talent, research institutions, and potential collaborators. It likely houses modern office and potentially laboratory spaces.
As a clinical-stage biopharmaceutical company, the work culture likely emphasizes scientific rigor, innovation, collaboration, and a strong sense of urgency driven by the goal of bringing new cancer treatments to patients. Employees are typically highly skilled and mission-driven.
The San Diego headquarters is critical for MEI Pharma's operations, strategic decision-making, and its ability to attract top talent in the competitive biotech landscape. Its location facilitates key partnerships and access to cutting-edge research.
MEI Pharma's global presence is primarily through its clinical trial activities, which may be conducted in multiple countries in collaboration with clinical research organizations (CROs) and investigational sites. Their corporate and R&D operations are based in the United States.
11975 El Camino Real, Suite 101
San Diego
CA
USA
Address: N/A
N/A
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, MEI Pharma' leadership includes:
MEI Pharma has been backed by several prominent investors over the years, including:
MEI Pharma has seen some key leadership transitions and appointments in the past year aimed at strengthening its operational and strategic capabilities.
Discover the tools MEI Pharma uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
MEI Pharma likely uses common corporate email formats. The most probable pattern is the first initial followed by the last name, or first name.last name.
[first_initial][last]@meipharma.com or [first].[last]@meipharma.com
Format
durso@meipharma.com
Example
80%
Success rate
MEI Pharma Press Release • May 9, 2024
MEI Pharma announced its financial results for the fiscal third quarter ended March 31, 2024, and provided updates on its clinical programs and corporate strategy, including progress on its lead drug candidates voruciclib and ME-344....more
MEI Pharma Press Release • March 19, 2024
MEI Pharma announced the initiation of a Phase 1b clinical trial evaluating voruciclib, an oral CDK9 inhibitor, in combination with venetoclax (Venclexta®) in patients with relapsed and refractory (R/R) acute myeloid leukemia (AML)....more
MEI Pharma Press Release • December 4, 2023
MEI Pharma announced the appointment of Justin E. Davis, Esq., as chief legal officer, effective December 4, 2023. Mr. Davis brings over 20 years of legal experience in the life sciences industry....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including MEI Pharma, are just a search away.